The All India Institute of Medical Sciences is planning to conduct a clinical trial of the convalescent plasma therapy in the treatment of Covid-19 patients, AIIMS Director Dr Randeep Guleria said on Tuesday. The modalities of taking the approval from the Drug Controller General of India (DCGI) is being worked out, official sources said.
Stating that the mode of treatment in Covid-19 is still at an "experimental stage", Guleria stressed on the need to have good and well-conducted research trials before its benefit, and this mode of therapy can be recommended for routine use in coronavirus patients. "AIIMS is working with the